X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Cargolux seals partnership with Sonoco Thermosafe

Content Team by Content Team
27th March 2019
in Manufacturing, Middle East and South Asia, News
Cargolux seals partnership with Sonoco Thermosafe

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Cargolux has signed a partnership agreement with Sonoco ThermoSafe, a leading global provider of temperature assurance packaging, for the leasing of the PharmaPort 360 temperature controlled bulk shipping container.

Cargolux is determined to offer its customers the best service possible and the latest available technology in transport solutions, especially when it comes to sensitive and time-critical shipments such as pharmaceuticals. The promise is upheld with leasing agreement such as this one that include numerous enhanced features. The state-of-the-art PharmaPort 360 containers are smart active containers, distinguished as the only active temperature controlled containers in the industry that include a fully integrated, FAA-approved telemetry system. They enable the provision of real-time, cloud-based data on payload and ambient temperature and key mechanical components, precisely synchronized with GPS location.

The use of these new containers provides a significant advantage for Cargolux’s pharmaceutical handling. As Franco Nanna, Cargolux’s Director Global Services highlights: “These containers go one step further in the secure and smooth transportation of sensitive commodities. Their cutting-edge features will strongly contribute to enhancing our service offering and confirm our position as leading airline for the transport of pharmaceuticals”.

A stance echoed by Sonoco, as Christopher Day, director of global business development for Sonoco ThermoSafe’s Leasing Services division states: “We are delighted to partner with Cargolux, the world’s first GDP certified airline, to provide one-way rentals of the best-in-class PharmaPort 360 temperature control containers. Given Cargolux’s unique global reach, this partnership further enables the pharmaceutical supply chain to cost-effectively ship PharmaPort 360s across the Americas, Africa, Europe and Asia-Pacific regions”.

The airline has a solid experience in the handling of delicate shipments and regularly carries pharmaceutical products across its extensive network. As the demand for such customized transports increases, Cargolux focuses on fine-tuning its dedicated solutions and supplying ever more sophisticated offers. As the world’s first GDP certified airline, Cargolux is committed to upholding its prime position as cargo carrier of choice for healthcare products.

Previous Post

N-Side Launches new innovative software for end-to-end Clinical Supply Chain Optimization

Next Post

WCG Introduces a Transformational Solution for Clinical Research Sites

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
WCG Introduces a Transformational Solution for Clinical Research Sites

WCG Introduces a Transformational Solution for Clinical Research Sites

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In